Follow-up of Endovascular Aneurysm Treatment - The FEAT Trial
Follow-up Study of Endovascular Abdominal Aortic Aneurysm Treatment
1 other identifier
observational
46
1 country
1
Brief Summary
After endovascular abdominal aortic aneurysm repair, life-long follow-up is needed to monitor the effectiveness of exclusion of the aneurysm sac from blood flow. For this reason, aneurysm diameter and the presence of endoleaks is evaluated with CT angiography yearly after Endovascular Aneurysm Repair (EVAR). The aim of this study is to investigate the value of MRA examinations for the follow-up of these patients. The advantages of MRA with respect to CTA are no use of ionizing radiation, use of less nephrotoxic contrast agents.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P25-P50 for all trials
Started Mar 2001
Longer than P75 for all trials
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
March 1, 2001
CompletedFirst Submitted
Initial submission to the registry
January 20, 2006
CompletedFirst Posted
Study publicly available on registry
January 24, 2006
CompletedStudy Completion
Last participant's last visit for all outcomes
March 1, 2009
CompletedFebruary 15, 2018
November 1, 2016
January 20, 2006
February 14, 2018
Conditions
Keywords
Interventions
Computed Tomography Angiography
Magnetic Resonance Angiography
Eligibility Criteria
Patient planned for endovascular abdominal aortic aneurysm repair
You may qualify if:
- Patient is planned for endovascular abdominal aortic aneurysm repair
You may not qualify if:
- contraindication for MRI examination
- claustrophobia
- pacemaker
- other non-MRI compatible implants
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
UMC Utrecht
Utrecht, 3584 CX, Netherlands
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
W. Mali, MD PhD
UMC Utrecht
Study Design
- Study Type
- observational
- Observational Model
- COHORT
- Time Perspective
- PROSPECTIVE
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR INVESTIGATOR
- PI Title
- Clinical research coordinator
Study Record Dates
First Submitted
January 20, 2006
First Posted
January 24, 2006
Study Start
March 1, 2001
Study Completion
March 1, 2009
Last Updated
February 15, 2018
Record last verified: 2016-11